Free Trial

Gerresheimer (ETR:GXI) Stock Price Up 0.9% - Here's Why

Gerresheimer logo with Medical background

Gerresheimer AG (ETR:GXI - Get Free Report) was up 0.9% on Wednesday . The company traded as high as €69.45 ($71.60) and last traded at €69.45 ($71.60). Approximately 202,264 shares were traded during mid-day trading, an increase of 44% from the average daily volume of 140,925 shares. The stock had previously closed at €68.85 ($70.98).

Gerresheimer Trading Up 0.9 %

The stock has a market cap of $2.40 billion, a PE ratio of 20.92, a PEG ratio of 0.82 and a beta of 0.94. The company has a current ratio of 0.87, a quick ratio of 0.40 and a debt-to-equity ratio of 79.36. The firm has a fifty day simple moving average of €74.44 and a two-hundred day simple moving average of €88.14.

Gerresheimer Company Profile

(Get Free Report)

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Gerresheimer Right Now?

Before you consider Gerresheimer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Gerresheimer wasn't on the list.

While Gerresheimer currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in February 2025
How To Invest in Crypto as A Complete BEGINNER in 2025
3 AI Bargain Stocks to BUY NOW After the DeepSeek Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines